SynAct Pharma AB's total assets for Q2 2025 were kr243.59M, an increase of 11.14% from the previous quarter. DE:8F8 total liabilities were kr47.18M for the fiscal quarter, a 24.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.